ArthNow Logo
ArthNow
•3 min read•
✦Reported by mint

Chemplast Sanmar shares jump over 11% in biggest single-day gain in 10 months as Q2 rally gathers pace

Chemplast Sanmar shares jump over 11% in biggest single-day gain in 10 months as Q2 rally gathers pace
Source: mint

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Chemplast Sanmar shares jumped 11.44% to ₹237 in Monday's trade after the company reported strong Q2 FY27 results.
  • ✓Revenue rose 28% to ₹1,323 crore, while the net loss narrowed to ₹5 crore.
  • ✓Investors cheered the performance, which pushed the stock to its highest level since May as trading volumes surged.

Story at a Glance

Category
Indian Markets
Reported By
mint
Reading Speed
3 Minute(s)
Market Focus
India Economy

Chemplast Sanmar shares jumped 11.44% to ₹237 after stronger-than-expected Q2 FY27 results. Revenue rose 28% year on year to ₹1,323 crore, EBITDA reached ₹111 crore, and net loss narrowed to ₹5 crore.

Speciality chemicals manufacturer Chemplast Sanmar saw its shares surge 11.44% to ₹237 apiece in Monday's trade, accompanied by a sharp uptick in trading volumes, with 16.5 million shares changing hands across the BSE and NSE.

The stock has been on an upward trajectory in recent sessions, as investors appeared to cheer the company's better-than-expected performance in the September quarter, pushing it to its highest level since May.

Chemplast Sanmar Q2 September 2026 results

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

mint

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.